Group 1 - The stock price of Fujilai as of August 11, 2025, closed at 37.44 yuan, down 0.58% from the previous trading day [1] - The trading volume on that day was 47,322 lots, with a transaction amount of 176 million yuan [1] - Fujilai's main business includes the research, production, and sales of pharmaceutical intermediates, active pharmaceutical ingredients, and formulations, primarily used in oncology, antiviral, and cardiovascular fields [1] Group 2 - As of July 31, 2025, the total number of shareholders for Fujilai was 13,377 [1] - The company is currently implementing a share repurchase plan, with further details to be announced in subsequent announcements [1] - On August 11, 2025, the net inflow of main funds was 2.2474 million yuan, with a cumulative net inflow of 31.5657 million yuan over the past five days [1]
富士莱股价小幅下跌 公司股份回购计划持续推进